Transcatheter aortic valve replacement: Current status and future directions

Chintan S. Desai, Eric E. Roselli, Lars G. Svensson, Robert O Bonow*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Transcatheter aortic valve replacement (TAVR) is a revolutionary therapy for patients with aortic stenosis. Large registries and randomized controlled trials have demonstrated that TAVR is safe and effective in patients considered inoperable because of severe comorbidities and those who are high-risk surgical candidates. As TAVR evolves for lower-risk patients, attention will need to focus on reducing the rates of vascular injury, stroke, and paravalvular regurgitation. In this review, we discuss the status of TAVR in clinical practice, including patient selection, preoperative evaluation, techniques, and complications.

Original languageEnglish (US)
Pages (from-to)193-196
Number of pages4
JournalSeminars in Thoracic and Cardiovascular Surgery
Issue number3
StatePublished - Dec 16 2013


  • Aortic stenosis
  • Aortic valve replacement
  • Transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Transcatheter aortic valve replacement: Current status and future directions'. Together they form a unique fingerprint.

Cite this